← All trials
NCT01243788
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2009
- Primary completion
- Feb 1, 2011
- Completion date
- Oct 1, 2011
- First posted
- —
- Last posted
- —
- Enrollment
- 450
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Fudan UniversityLead sponsor
- Armed Police General Hospital, P. R. ChinaCollaborator
- Fudan UniversityOverall official - principal investigator
- Qingdao UniversityCollaborator
- Fudan UniversityCollaborator
- Sichuan UniversityCollaborator
- Henan Medical UniversityCollaborator
- Capital Medical UniversityCollaborator
- Liaoning Province North HospitalCollaborator
- Anhui College of Traditional Chinese MedicineCollaborator
- Guangzhou Medical UniversityCollaborator
- Nanjing Medical UniversityCollaborator
- Tsinghua UniversityCollaborator
- Peking UniversityCollaborator
- People's Liberation Army of ChinaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.